---
title: "Suven Life Sciences Ltd (SUVEN) — Share Price, Financials & Analysis"
symbol: "SUVEN"
company: "Suven Life Sciences Ltd"
canonical: "https://tapetide.com/stocks/SUVEN"
isin: "INE495B01038"
nse_symbol: "SUVEN"
bse_code: "530239"
sector: "Healthcare"
industry: "Healthcare Services"
market_cap_cr: 9988.59
generated_at: "2026-09-13T18:37:43.083Z"
---

# Suven Life Sciences Ltd (SUVEN)

Canonical page: https://tapetide.com/stocks/SUVEN

## Company

- **NSE Symbol:** SUVEN
- **BSE Code:** 530239
- **ISIN:** INE495B01038
- **Sector:** Healthcare
- **Industry:** Healthcare Services
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2003-10-23
- **CEO:** Mr. Venkateswarlu Jasti M.Pharm. M.S.
- **Employees:** 138
- **Face Value:** ₹1
- **F&O Eligible:** No
- **Website:** suven.com

## About

Suven Life Sciences is a clinical-stage biopharmaceutical company developing proprietary New Chemical Entities for central nervous system disorders. Its five clinical assets target agitation in Alzheimer’s dementia, narcolepsy, major depressive disorder and cognitive disorders.[1] [2]

## Latest Price

- **Price:** ₹355.55
- **Change:** -5.15 (-1.43%)
- **Open:** ₹355
- **Day High:** ₹359.95
- **Day Low:** ₹351.5
- **Previous Close:** ₹360.7
- **Volume:** 369913
- **As Of:** 2026-09-11T10:25:02+00:00

## Key Fundamentals

Observed at 2026-09-11T04:48:24.047071Z.

- **Market Cap:** ₹9988.59 Cr
- **Classification:** Microcap
- **P/E (reported):** -29
- **EPS (TTM):** ₹-14.44
- **Book Value:** ₹24.23
- **Price to Book:** 14.92
- **Dividend Yield:** 0%
- **ROE:** -46.73%
- **ROCE:** -45.62%
- **Debt to Equity:** 0.03
- **Revenue (yearly):** ₹21 Cr
- **Net Income:** ₹-276.3 Cr
- **EBITDA:** ₹-270.6 Cr
- **52-Week High:** ₹403.35
- **52-Week Low:** ₹124.11
- **RSI (14):** 51.99

## Tapetide Score

- **Score:** 31 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Rising
- **Percentile:** 2.7 (of 4473 scored stocks)
- **Confidence:** 91%
- **Data coverage:** 81%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 47.26 | 9% |
| growth | 51.26 | 9% |
| momentum | 98.3 | 12% |
| ownership | 50.11 | 24% |
| quality | 2.79 | 22% |
| valuation | 6.78 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.

### Weaknesses

- Stock is trading at 15.9 times its book value
- Company has low interest coverage ratio.
- Promoter holding has decreased over last quarter: -4.68%
- The company has delivered a poor sales growth of -12.0% over past five years.
- Company has a low return on equity of -65.9% over last 3 years.
- Debtor days have increased from 63.7 to 77.5 days.
- Working capital days have increased from 55.6 days to 506 days

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -93.1% | -159.72% | -135.14% |
| ebitda margin growth | -184.74% | 45.71% | 294.86% | 43.12% |
| net income growth | -179.82% | 71.94% | 162.89% | 126.48% |
| revenue growth | 33.73% | 19.32% | -19% | -12% |
| roce | 179.78% | -68.29% | 16.88% | -76.31% |
| roe | 179.85% | -68.03% | -77.26% | -63.17% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 3 | 2 | 2 | 1 | 3 | 2 | 1 | 2 | 1 | 3 | 2 | 4 |
| Expenses | 27 | 49 | 33 | 32 | 55 | 41 | 45 | 53 | 81 | 106 | 52 | 136 |
| Operating Profit | -24 | -46 | -30 | -31 | -52 | -39 | -44 | -51 | -80 | -103 | -51 | -132 |
| OPM % | -768 | -1885 | -1267 | -3024 | -2032 | -2435 | -2981 | -2714 | -8671 | -3678 | -3331 | -3711 |
| Other Income | 13 | 6 | 4 | 4 | 4 | 2 | 1 | 1 | 4 | 3 | 7 | 8 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 2 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 2 | 2 |
| Profit before tax | -13 | -42 | -28 | -28 | -50 | -39 | -44 | -52 | -77 | -102 | -46 | -128 |
| Tax % | 0 | 0 | -4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -13 | -42 | -27 | -28 | -50 | -39 | -44 | -52 | -77 | -102 | -46 | -128 |
| EPS in Rs | -0.58 | -1.91 | -1.22 | -1.29 | -2.28 | -1.79 | -2.01 | -2.36 | -3.4 | -4.48 | -1.73 | -4.83 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 625 | 286 | 13 | 13 | 12 | 14 | 12 | 7 | 7 | 9 |
| Expenses | 427 | 300 | 128 | 93 | 134 | 139 | 140 | 172 | 291 | 375 |
| Operating Profit | 198 | -14 | -116 | -80 | -122 | -126 | -128 | -166 | -284 | -366 |
| OPM % | 32 | -5 | -917 | -593 | -1032 | -929 | -1094 | -2487 | -3999 | -4152 |
| Other Income | 23 | 27 | 14 | 8 | 5 | 14 | 29 | 11 | 14 | 21 |
| Interest | 5 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| Depreciation | 21 | 11 | 4 | 4 | 4 | 7 | 6 | 6 | 6 | 6 |
| Profit before tax | 196 | 0 | -106 | -77 | -122 | -118 | -106 | -161 | -276 | -352 |
| Tax % | 37 | 15038 | -11 | -7 | 0 | 0 | -1 | 0 | 0 | — |
| Net Profit | 124 | -24 | -94 | -72 | -122 | -118 | -105 | -161 | -276 | -352 |
| EPS in Rs | 6.48 | -1.25 | -4.94 | -3.78 | -5.59 | -5.42 | -4.82 | -7.37 | -10.48 | -14.44 |
| Dividend Payout % | 15 | -80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 13 | 13 | 13 | 13 | 13 | 15 | 22 | 22 | 22 | 26 |
| Reserves | 654 | 755 | 226 | 131 | 95 | 82 | 354 | 248 | 88 | 565 |
| Borrowings | 71 | 34 | 3 | 6 | 5 | 3 | 2 | 1 | 0 | 17 |
| Other Liabilities | 78 | 118 | 62 | 33 | 16 | 9 | 12 | 14 | 25 | 16 |
| Total Liabilities | 816 | 919 | 303 | 182 | 128 | 108 | 389 | 285 | 135 | 624 |
| Fixed Assets | 306 | 308 | 22 | 25 | 21 | 38 | 37 | 28 | 60 | 73 |
| CWIP | 10 | 25 | 0 | 0 | 5 | 4 | 0 | 0 | 0 | 4 |
| Investments | 301 | 279 | 223 | 0 | 0 | 45 | 46 | 76 | 22 | 181 |
| Other Assets | 199 | 308 | 58 | 157 | 103 | 22 | 305 | 181 | 53 | 367 |
| Total Assets | 816 | 919 | 303 | 182 | 128 | 108 | 389 | 285 | 135 | 624 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 109 | 70 | -53 | -135 | -96 | -128 | -116 | -115 | -155 | -300 |
| Cash from Investing Activity | -311 | -1 | 30 | 146 | 56 | -22 | -248 | 94 | 155 | -462 |
| Cash from Financing Activity | -30 | -52 | 5 | 3 | 35 | 146 | 396 | -1 | -1 | 757 |
| Net Cash Flow | -232 | 17 | -18 | 14 | -5 | -4 | 32 | -22 | -1 | -5 |
| Free Cash Flow | 79 | 28 | -92 | -137 | -102 | -147 | -119 | -113 | -193 | -305 |
| CFO/OP | 111 | 57 | 262 | 114 | 119 | 104 | 91 | 95 | 93 | 106 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 31 | 36 | 3 | 66 | 48 | 40 | 22 | 40 | 73 | 78 |
| Inventory Days | 222 | 329 | 0 | — | — | — | — | — | — | — |
| Days Payable | 91 | 134 | — | — | — | — | — | — | — | — |
| Cash Conversion Cycle | 162 | 231 | 3 | 66 | 48 | 40 | 22 | 40 | 73 | 78 |
| Working Capital Days | 42 | 82 | 23 | 704 | 1084 | 234 | 265 | 101 | -440 | 506 |
| ROCE % | 15 | 24 | -4 | -54 | -58 | -118 | -53 | -36 | -87 | -80 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 69.57% | 69.57% | 69.57% | 70.27% | 70.27% | 70.27% | 70.27% | 70.27% | 67.36% | 67.36% | 70.15% | 70.08% |
| FIIs | 0.5% | 0.54% | 0.46% | 0.45% | 0.34% | 0.34% | 0.25% | 0.59% | 1.18% | 1.07% | 0.91% | 0.57% |
| DIIs | 0.01% | 0.12% | 1.17% | 1.17% | 1.05% | 1.06% | 0.01% | 0.02% | 3.39% | 3.39% | 4.62% | 2.93% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 24.38% | 24.05% | 22.29% | 22.66% | 22.15% | 22.31% | 24.04% | 23.17% | 22.25% | 22.29% | 19.45% | 21.37% |
| Others | 5.54% | 5.72% | 6.51% | 5.46% | 6.19% | 6.04% | 5.44% | 5.95% | 5.82% | 5.9% | 4.87% | 5.06% |
| No. of Shareholders | 80953 | 74003 | 68959 | 66116 | 63975 | 63537 | 64603 | 66159 | 64921 | 64381 | 64037 | 66791 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 10 / 3 / 6

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 372.37 | Sell |
| EMA (10) | 365.75 | Sell |
| SMA (20) | 365.55 | Sell |
| EMA (20) | 361.33 | Sell |
| SMA (50) | 342.13 | Buy |
| EMA (50) | 337.74 | Buy |
| SMA (100) | 296.03 | Buy |
| EMA (100) | 301.1 | Buy |
| SMA (200) | 226.74 | Buy |
| EMA (200) | 258.62 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 49.69 | Neutral |
| MACD (12,26,9) | 8.54 | Sell |
| Stochastic (14,3,3) | 8.19 | Buy |
| ADX (14) | 33.3 | Buy |
| Williams %R (14) | -92.19 | Buy |
| ATR (14) | 18.06 | High Volatility |
| ROC (12) | -4.47 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 30.1 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-03 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae33ce45-3ecd-4592-bebb-35e679582c5d.pdf) |
| 2026-08-25 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b94ff73-4c6d-4e9c-95a1-c81ade882fae.pdf) |
| 2026-08-25 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8cf5ee9b-7f1c-4aef-a451-afd847fdf7f7.pdf) |
| 2026-08-11 | [Announcement under Regulation 30 (LODR)-Monitoring Agency Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d93c0da4-393e-4323-9d81-c0cee837e81c.pdf) |
| 2026-08-07 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=64f3d29f-ee1c-48d8-9c81-f64da9a094d5.pdf) |
| 2026-08-06 | [Board Meeting Outcome for Un-Audited Financial Results For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22285030-85f8-4566-87ae-5cfe9b8cfe18.pdf) |
| 2026-07-31 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7b20713a-d592-4ced-a4e2-d3ea4633d28d.pdf) |
| 2026-07-30 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d842c52f-a78a-46ea-b714-09a2f844f362.pdf) |
| 2026-07-30 | [Notice Of 37Th Annual General Meeting (AGM) Of The Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cfb5b1c6-90e0-49ea-9fc0-13dfc6baadc8.pdf) |
| 2026-07-30 | [Business Responsibility and Sustainability Reporting (BRSR)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57b28123-06b8-4240-942b-7211ef9e86df.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-06 | [Un-Audited Financial Results For The Quarter Ended 30Th June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de075aab-ebec-4538-b3e1-3fa6991d355c.pdf) |
| 2026-05-13 | [Outcome Of The Meeting Of Board Of Directors Held On May 13 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc6d72c2-6f26-41ec-b540-67150e660e3e.pdf) |
| 2026-01-29 | [Outcome Of The Meeting Of Board Of Directors Of Suven Life Sciences Limited Held On Thursday January 29 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53a8685c-d3eb-4379-9287-5c17c2b75298.pdf) |
| 2025-11-11 | [Un-Audited Standalone And Consolidated Financial Results For Quarter And Half-Year Ended 30Th September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee3e4729-f9b9-4769-bd90-bb7697fabedb.pdf) |
| 2025-08-13 | [Outcome Of The Meeting Of Board Of Directors Of Suven Life Sciences Limited Held On August 13 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=774615df-d0c7-4863-94cf-5329f3819b82.pdf) |
| 2025-05-13 | [Outcome Of The Meeting Of Board Of Directors Of Suven Life Sciences Limited Held On Tuesday May 13 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4adfffe6-a28c-4a70-b253-6033aeeeaa24.pdf) |
| 2025-01-24 | [Outcome Of The Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5bfb90b-5201-437c-8a58-0283a6c041da.pdf) |
| 2024-10-29 | [Outcome Of The Board Meeting - Financial Results For Quarter & Half-Year Ended 30/09/2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4b56badf-d825-4a5a-a0c6-0a5caec32916.pdf) |
| 2024-08-05 | [Outcome Of The Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26dc718e-99e0-4b07-99f5-a3b4c3e1a5fc.pdf) |
| 2024-05-06 | [Approved The Attached Audited Standalone And Consolidated Financial Results For The Quarter And Financial Year Ended March 31, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=834c95fc-b65b-4e7d-b890-4be7a02eebd6.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 8 Apr - Company clarifies recent price movement is due to market speculation; no material announcement pending. | [Clarification On Price Movement 8 Apr - Company clarifies recent price movement is due to market speculation; no material announcement pending.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/069781df-049b-45ba-9ff6-e81e5942e16c.pdf) |
| 6 May - Board meets May 13, 2026 to approve FY26 audited standalone and consolidated results; trading window closed until May 15. | [Board Meeting Intimation for Consideration Of Audited Financial Results (Standalone And Consoldiated) For The Quarter And Financial Year Ended 31 March, 2026. 6 May - Board meets May 13, 2026 to approve FY26 audited standalone and consolidated results; trading window closed until May 15.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/6c5b93cd-aca7-4154-b4ce-9ebde2c32305.pdf) |
| 6 Mar - Allotted 31,768,764 shares to promoter at Rs.134 each; proceeds Rs.425.70 crore. | [Announcement under Regulation 30 (LODR)-Allotment 6 Mar - Allotted 31,768,764 shares to promoter at Rs.134 each; proceeds Rs.425.70 crore.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/dcb3a6d4-5424-4a0e-b15d-86993fd7d363.pdf) |
| 6 Mar - 3,17,68,764 shares allotted to Jasti Property at Rs134 on March 6, 2026; proceeds Rs4,257,014,376. | [Board Meeting Outcome for ALLOTMENT OF 3,17,68,764 EQUITY SHARES OF THE COMPANY ON PREFERENTIAL BASIS 6 Mar - 3,17,68,764 shares allotted to Jasti Property at Rs134 on March 6, 2026; proceeds Rs4,257,014,376.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/58801ac4-6782-4e9f-bb7d-ea4b1b7ff1b0.pdf) |
| 6 Feb - Suven clarifies on Feb 6, 2026: no material Reg 30 event; price moves due to market speculation. | [Clarification On Price Movement 6 Feb - Suven clarifies on Feb 6, 2026: no material Reg 30 event; price moves due to market speculation.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/880bc465-6c6d-4056-b8b7-63c2472c394d.pdf) |
| 6 Apr - Submitted Regulation 74(5) depository compliance certificate for quarter ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6 Apr - Submitted Regulation 74(5) depository compliance certificate for quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5f2127e7-9553-4ca7-8ba4-40d2f09155ef.pdf) |
| 23 Apr - Window for Re-Lodgment of transfer requests of Physical shares | [Announcement under Regulation 30 (LODR)-Newspaper Publication 23 Apr - Window for Re-Lodgment of transfer requests of Physical shares](https://www.bseindia.com/xml-data/corpfiling/AttachHis/82033cfd-b1b2-40df-bda2-ea9b8312c314.pdf) |
| 19 Feb - Window for Re-lodgment of transfer requests of physical securities | [Announcement under Regulation 30 (LODR)-Newspaper Publication 19 Feb - Window for Re-lodgment of transfer requests of physical securities](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ba106b59-afed-4378-8880-e274b2cd0964.pdf) |
| 14h - Window for Re-Lodgment of transfer requests of Physical shares | [Announcement under Regulation 30 (LODR)-Newspaper Publication 14h - Window for Re-Lodgment of transfer requests of Physical shares](https://www.bseindia.com/xml-data/corpfiling/AttachLive/82033cfd-b1b2-40df-bda2-ea9b8312c314.pdf) |
| — | [Closure of Trading Window 25 Mar](https://www.bseindia.com/xml-data/corpfiling/AttachHis/44e5ec20-6816-42c1-9649-89986c4048cc.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2013 from nse](https://archives.nseindia.com/annual_reports/AR_626_SUVEN_2012_2013_18072013133822.zip) |
| from nse | [Financial Year 2012 from nse](https://archives.nseindia.com/annual_reports/AR_SUVEN_2011_2012_17092012101920.zip) |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d842c52f-a78a-46ea-b714-09a2f844f362.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bc784565-74c0-4ad4-a9a2-a1f42a10f668.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/007c45d2-6a1a-4596-8455-e89552d6590a.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1e2a033c-5ad7-4d57-9176-ed4b9d24b49d.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/530239/73608530239.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/530239/68890530239.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/530239/64963530239_18_09_20.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/530239/5302390319.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2018 | [Concall - Nov 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=47caa749-73fb-4c24-bbe9-6cd9e3dd3f6c.pdf) |
| Nov 2018 | [Concall - Nov 2018](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2018/11/47caa749-73fb-4c24-bbe9-6cd9e3dd3f6c.pdf) |
| May 2019 | [Concall - May 2019](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b3f7a0f1-cef7-4365-9f57-5b5e7c538aaf.pdf) |
| May 2019 | [Concall - May 2019](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b3f7a0f1-cef7-4365-9f57-5b5e7c538aaf.pdf) |
| May 2017 | [Concall - May 2017](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26b466f4-2b41-4ba4-9ea2-b68f89d9a788.pdf) |
| May 2017 | [Concall - May 2017](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2017/5/26b466f4-2b41-4ba4-9ea2-b68f89d9a788.pdf) |
| Jun 2017 | [Concall - Jun 2017](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=009c9471-3000-4cc2-9e71-9af43b43e7ac.pdf) |
| Jun 2017 | [Concall - Jun 2017](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fcab458e-5b71-4426-a345-e3174ae53b30.pdf) |
| Jun 2017 | [Concall - Jun 2017](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2017/6/009c9471-3000-4cc2-9e71-9af43b43e7ac.pdf) |
| Jun 2017 | [Concall - Jun 2017](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2017/6/fcab458e-5b71-4426-a345-e3174ae53b30.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:37:43.083Z.